To the editor:
Patients suffering from anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) fail to activate the canonical nuclear factor-κB (NF-κB) pathway due to mutations in the IKKG (inhibitory κB kinase gamma) gene encoding IKKγ, also known as NEMO (NF-κB essential modulator).1 This results in a combined cellular and humoral immune defect. In a recent study by Luengo-Blanco et al, the authors conclude that NF-κB activity is required for the transcription of the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase genes CYBB and NCF1, encoding gp91phox and p47phox, respectively.2 Both proteins are essential components of the NADPH-oxidase complex, and in patients with chronic granulomatous disease (CGD) failure to express these proteins results in a severe immunodeficiency.3 Luengo-Blanco et al base their conclusions on studies with Epstein-Barr virus (EBV)–transformed B-cell lines from patients diagnosed with EDA-ID as well as studies with pharmacologic inhibitors of NF-κB activation in the monocytic cell line U937 and repressor transfected U937 cells. In these model systems, expression of gp91phox and p47phox was severely impaired, resulting in a failure to activate the NADPH oxidase upon stimulation with phorbol 12-myristate 13-acetate (PMA), similar to EBV-transformed B cell lines from CGD patients.2
Recently, we had the opportunity to perform functional tests with primary neutrophils from 3 different EDA-ID patients. The patients were 1, 2 and 5 years of age at the time of investigation. The second patient was the brother of the third. All 3 patients had variable degrees of dermatitis and minor peripheral lymphadenopathy since birth, as well as recurrent bacterial infections, and had the pale, sparse hair and conical incisors typical for EDA-ID patients.1 The genetic defects were all identified in the IKBKG gene resulting in a stop codon (p.Q365X) in exon 9 (c.1093C>T) in one patient and a missense mutation (p.Q205P) in exon 5 (c.614A>C) in the other 2 patients. NF-κB activation was severely impaired in all 3 patients, as demonstrated in Figure 1A by a significantly reduced production of interleukin-8 (IL-8), when determined by ELISA after overnight stimulation of the isolated neutrophils with lipopolysaccharide (LPS, 10 ng/mL) and lipid binding protein (LBP, 50 ng/mL). However, in contrast to the results from Luengo-Blanco et al, NADPH-oxidase activity was completely normal in the neutrophils of these EDA-ID patients upon stimulation with various stimuli, as shown in Figure 1B. In addition, expression of both gp91phox and p67phox were found to be relatively normal in the neutrophils of the patients (Figure 1C). This suggests that, at least in primary neutrophils, NEMO-dependent NF-κB activation is not required for the expression and function of the NADPH oxidase. Instead, the recurrent bacterial infections in our EDA-ID patients seem to be due to the poor antibody reactivity against (encapsulated) pathogens (not shown),1 possibly combined with a failure to produce proinflammatory cytokines to recruit phagocytes to the site of infection (Figure 1A).
We suggest that the results of Luengo-Blanco et al, which were all obtained from in vitro–cultured model cell lines, can be explained by a failure to differentiate these NF-κB–deficient model cell lines in vitro to fully functional phagocytes or B cells. Primary phagocytes, or at least neutrophils, that differentiate in vivo under different circumstances, do not appear to depend on NF-κB activity for the expression of the NADPH oxidase.
Authorship
Conflict-of-interest-disclosure: The authors declare no competing financial interests.
Correspondence: Bram J. van Raam, Burnham Institute for Medical Research, 10901 North Torrey Pines Rd, La Jolla, CA 92037; e-mail: B.J.vanRaam@gmail.com.